Feedback (LON:FDBK) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why

Shares of Feedback plc (LON:FDBK) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 12.30 and traded as high as GBX 13.50. Feedback shares last traded at GBX 12.70, with a volume of 50,875 shares changing hands.

Feedback Price Performance

The company’s 50 day simple moving average is GBX 12.30 and its 200 day simple moving average is GBX 10.67. The firm has a market cap of £5.56 million, a price-to-earnings ratio of -0.81 and a beta of 0.77.

Feedback (LON:FDBK) last announced its quarterly earnings data on Tuesday, February 17th. The company reported GBX (3.98) earnings per share (EPS) for the quarter. Feedback had a negative net margin of 845.25% and a negative return on equity of 135.17%. As a group, analysts forecast that Feedback plc will post -8 earnings per share for the current year.

Insider Activity

In related news, insider Emma Oswick (Stuart) acquired 60,459 shares of the firm’s stock in a transaction dated Tuesday, December 23rd. The stock was acquired at an average price of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley acquired 60,904 shares of the firm’s stock in a transaction dated Tuesday, December 23rd. The stock was bought at an average price of GBX 8 per share, with a total value of £4,872.32. 7.98% of the stock is owned by corporate insiders.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.